Journal Article DKFZ-2020-00752

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2020
Elsevier Amsterdam [u.a.]

The journal of molecular diagnostics 22(6), 801-810 () [10.1016/j.jmoldx.2020.03.005]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: In this manuscript we compare the expression and applicability of biomarkers, from single genes and gene signatures, identified in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) using the GeneChip Human Transcriptome Array 2.0, nCounter and real-time polymerase chain reaction (RT-PCR) analyses. Two multicentre retrospective HNSCC patient cohorts of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG), who received postoperative radiochemotherapy (PORT-C) or primary radiochemotherapy (primary RCTx) were considered. RT-PCR was performed for a limited number of 38 genes of the PORT-C cohort only. Correlations between the methods were evaluated by the Spearman rank correlation coefficient ρ. Patients were stratified based on the expression of putative cancer stem cell markers, hypoxia-associated gene signatures and a previously developed 7-gene signature. Loco-regional tumour control (LRC) was compared between these patient subgroups using log-rank tests. Gene expressions obtained from nCounter analyses were moderately correlated to GeneChip analyses (median ρ≈0.68). A higher correlation was obtained between nCounter analyses and RT-PCR (median ρ=0.84). Significant associations to LRC were observed for most of the considered biomarkers evaluated by both GeneChip and nCounter analyses. In general, all applied biomarkers (single genes and gene signatures) classified about 70% to 85% of the patients similarly. Overall, gene signatures seem to be more robust and showed a better transferability between different measurement methods.

Classification:

Note: 2020 Jun;22(6):801-810

Contributing Institute(s):
  1. DKTK DD zentral (DD01)
  2. DKTK BE zentral (BE01)
  3. DKTK ED ES zentral (ED01)
  4. DKTK FM zentral (FM01)
  5. DKTK HD zentral (HD01)
  6. DKTK FR zentral (FR01)
  7. DKTK MU LMU zentral (MU01)
  8. E210 Translationale Radioonkologie (E210)
  9. E050 KKE Strahlentherapie (E050)
  10. DKTK TU zentral (TU01)
Research Program(s):
  1. 315 - Imaging and radiooncology (POF3-315) (POF3-315)

Appears in the scientific report 2020
Database coverage:
Medline ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2020-04-06, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)